Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

HelixNano

HelixNano leverages synthetic biology and AI to safely and reliably express transgenes in humans – for next-generation gene therapies, genome engineering and beyond. 

  • Hannu Rajaniemi, PhD Chief Executive Officer
  • Nikolai Eroshenko, PhD Chief Scientific Officer